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Abstract
Background: Rotavirus is one of the leading causes of childhood diarrhoea worldwide. The highest disease burden
is seen in resource-constrained settings of sub-Saharan Africa. Recently, commercial multiplex PCR panels proved
their accuracy to diagnose infectious gastroenteritis in Europe and the USA. However, data on their performance
using samples from tropical regions in general and to detect rotavirus in particular remains scant. We aimed to
analyse the diagnostic performance of the Luminex xTAG gastrointestinal pathogens panel, a multiplex PCR, to
detect rotavirus in stool samples from Ghanaian children.
Methods: A total of 682 stool samples were collected in the Ashanti region of Ghana between 2007 and 2008. Of
these, 341 were from cases (children with diarrhoea), and another 341 from controls (children without diarrhoea). All
samples were analysed using the Luminex xTAG assay and compared to a rotavirus quantitative reverse-transcription
PCR (reference assay). Rotavirus reference assay positive samples were P and G genotyped by sequencing the rotavirus
VP4 and VP7 genes.
Results: Overall agreement between the Luminex xTAG and the reference assay was excellent (kappa 0.93). The
sensitivity and specificity was 88.2 % (95 % confidence interval [CI] 78.2–94.1) and 100 % (95 % CI 99.2–100),
respectively. Of 76 rotavirus reference assay positive samples, 64 were successfully genotyped and the Luminex xTAG
assay was able to detect all rotavirus genotypes present in the study.
Conclusion: The Luminex xTAG assay proved a sensitive and highly specific tool to detect rotavirus and may aid
clinicians and public health authorities in the diagnosis and surveillance of rotavirus.
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Background
Rotavirus gastroenteritis is a major public health threat
responsible for a high disease burden in low-income
countries [1]. Laboratory diagnosis of rotavirus gastro-
enteritis is traditionally accomplished using enzyme-
immunoassays (EIA) and current EIA kits demonstrated
a good overall performance [2]. However, PCR methods
have proven their advantages over conventional methods
mainly due to a higher analytical sensitivity [3, 4]. Com-
mercial multiplex PCR panels became available recently
allowing the simultaneous detection of several targets in-
cluding rotavirus. These panels were already successfully
evaluated in Europe, the USA, and more recently in
Vietnam [5–7]. We applied the Luminex xTAG gastro-
intestinal pathogens panel (GPP) in a rural African set-
ting and could demonstrate a high rate of positive stool
samples [8]. The assay was applied to diagnose gastro-
intestinal pathogens in children with and without diar-
rhoea to evaluate the usefulness of the GPP. Overall the
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three most common pathogens were enterotoxigenic
Escherichia coli, Giardia lamblia, and Shigella spp.. In
particular, we could show an association with diarrhoea
for rotavirus. However, there is only scant evidence on
the diagnostic performance of commercial multiplex
PCR panels using samples from tropical settings in gen-
eral and to detect rotavirus in particular.
We aimed to evaluate the performance of the Luminex
xTAG GPP multiplex PCR in comparison to a reference
quantitative reverse-transcription PCR (qRT-PCR) to de-
tect rotavirus in stool samples from Ghanaian children.
Results
Among cases, 49/341 (14.4 %) tested positive using qRT-
PCR, and 44/341 (12.9 %) tested positive using the GPP.
In controls, 27/341 (7.9 %) were qRT-PCR positive, and
23/341 (6.7 %) were positive using the GPP assay.
Comparable qRT-PCR Ct-values between cases (median
Ct-value: 21.5, interquartile range [IQR]: 19.8; 25.1) and
controls (median Ct-value: 22.0, IQR: 19.2; 27.0) were ob-
served (p = 0.66). Rotavirus was detected more frequently
in cases (n = 49, 14.4 %) compared to controls (n = 27,
7.9 %) using qRT-PCR (p = 0.010), and GPP (n = 44,
12.9 % versus n = 23, 6.7 %; p = 0.009), respectively.
Overall agreement between qRT-PCR and GPP was
excellent (kappa 0,93). The test performance of the GPP
in comparison to qRT-PCR is summarized in Table 1. In
cases, the sensitivity of GPP was slightly higher (Table 1).
The nine GPP false-negative results had a median qRT-
PCR Ct-value of 30 (IQR: 28.8; 32.5) indicating low rota-
virus loads. Of note, all nine samples tested rotavirus
positive using the FTD viral gastroenteritis assay, sug-
gesting that these samples were indeed GPP false-
negatives. Five of these nine samples were from cases,
and four from controls.
There was a significant difference in qRT-PCR Ct-
values between 44 GPP-positive (median Ct-value: 21,
IQR: 19.8; 23.3) and five GPP-negative cases (median
Ct-value: 29, IQR: 27.5; 29.8, p = 0.0001) (Fig. 1). Of the
76 qRT-PCR positive samples 64 (84 %) were rotavirus
G and P genotyped. The GPP assay was able to detect all
rotavirus genotypes present in the study (Table 2). Of
note, we failed to genotype the nine GPP false-negative
samples.
Comparable MFI-values using the GPP assay be-
tween cases (median MFI: 3875; IQR: 2791; 4795) and
controls (median MFI: 3314, IQR: 2173; 4485) were
observed (p = 0.33). Next, we analyzed GPP MFI-
values in four different groups with qRT-PCR Ct-
values <20 (median MFI: 4475, IQR: 3766; 4960), 20-
25 (median MFI: 3505, IQR: 2583; 4414), 25–30 (me-
dian MFI: 1694, IQR: 145; 2882), and >30 (median
MFI: 46, IQR: 44; 63), respectively (Fig. 2). There was
a statistically significant difference between the groups
with Ct-values ranging from 20–25, 25–30, and >30,
respectively, using one-way ANOVA analysis. Only a
weak negative correlation of −0.47 (95 % CI −6.64 to
−0.26) was seen between qRT-PCR values and GPP
MFI-values.
Finally, the number of co-detections with other patho-
gens as determined using the GPP did not differ signifi-
cantly between cases (median 3, IQR: 2; 3) and controls
(median 2, IQR: 1; 4), and between GPP-positive (me-
dian 2, IQR: 1; 3) and GPP-negative (median 2, IQR: 2;
4) samples. Overall the rate of co-detections was statis-
tical significantly different between rotavirus GPP-
positive [67/67 (100 %)] and GPP-negative [575/615
(93.5 %)] samples (Fishers exact test, p = 0.025). The dis-
tribution of pathogens among rotavirus GPP-positive
and rotavirus GPP-negative samples is shown in Table 3.
Of note, significantly more enterotoxigenic Escherichia
coli (59 % versus 43 %, p = 0,0187), Escherichia coli
O157 (15 % versus 3 %, p = 0,0029), and Shigella spp.
(40 % versus 22 %, p = 0,0052) were detected among
rotavirus GPP-negative samples compared to GPP-
positive samples (Table 3).
Discussion
We could show an excellent agreement between the
GPP and qRT-PCR to detect rotavirus in stool samples
from Ghanaian children. The high specificity of the GPP
is reassuring. The sensitivity of the GPP to detect rota-
virus was slightly lower than reported previously [5, 9].
However, numbers of rotavirus positive samples were ra-
ther low in both studies [5, 9]. Another study from
Vietnam used a comprehensive panel of samples and
demonstrated a sensitivity of 92.2 % and specificity of
98.9 %, respectively, for rotavirus [7]. These data from
an Asian tropical country are in line with our findings
although different rotavirus qRT-PCR assays were used
as a comparator. On the other hand, rare rotavirus geno-
types or genetic variants which are prevalent in West
Africa might undergo GPP detection, but warrants fur-
ther studies [10]. As a limitation we could not sequence
Table 1 Performance of the Luminex GPP in comparison to the rotavirus reference qRT-PCR assay among all study subjects (top
panel) and cases only (bottom panel)
TP, n FP, n FN, n TN, n Sensitivity % (95 % CI) Specificity % (95 % CI) kappa
All study subjects (n = 682) 67 0 9 606 88.2 (78.2–94.1) 100 (99.2–100) 0.93
Cases (n = 341) 44 0 5 292 89.7 (76.9–96.2) 100 (98.4–100) 0.94
TP true positive; FP false positive; FN false negative; TN true negative
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the qRT-PCR positive/GPP negative samples mainly due
to low virus concentrations. Little left over material pre-
vented further sequencing efforts.
Intriguingly, we detected less rotavirus shedding
among controls using GPP and qRT-PCR compared to a
recent study from Malawi [11]. Differences in herd im-
munity are possible reasons for this finding. However,
rotavirus shedding using RT-PCR has been observed in
different studies but the relevance remains unclear [12].
Subclinical infections or prolonged shedding after acute
infections might play a role and deserve further studies.
In light of the high sensitivity of the qRT-PCR and
consistency with GPP results it is less likely that sensitiv-
ity issues played a role. Interestingly, the median qRT-
PCR Ct-value of GPP-positive cases in our study is close
to the Ct-value of 19.5 in diarrheal cases of another
study supporting the notion that low Ct-values are asso-
ciated with clinically relevant disease [11]. Of note, the
results of the GPP are of qualitative nature only and
quantitative results might provide a better resolution of
PCR results and disease [13]. As a surrogate marker for
rotavirus RNA concentrations we could show that MFI
values of the GPP might provide useful semi-
quantitative information. However, further studies are
needed to establish reliable quantitative data using the
GPP. Ultimately, studies are needed to appreciate the
value of multiplex PCR in order to improve patient care.
As a limitation of our study we did not address the diag-
nostic performance of all pathogens included in the GPP
panel. Previous studies have shown a good overall per-
formance but further studies using samples from Africa
are needed.
Conclusion
We evaluated the Luminex GPP assay to detect rotavirus
using stool samples from Ghanaian children and could
demonstrate that the Luminex GPP is a sensitive and
highly specific tool for this purpose. The GPP is able to
detect a broad range of rotavirus genotypes prevalent in
Ghana and our results suggest that the assay can provide
semi-quantitative data which requires further investiga-
tion. Thus, pending its implementation in resource-
constrained African countries the GPP assay might pro-
vide a valuable tool in the detection and surveillance of
rotavirus.
Methods
Samples used in the current study were a subset of sam-
ples collected in the framework of a case-control study
on causes of diarrhoea in children. The study was con-
ducted at the children’s Outpatients Department (OPD)
of the Agogo Presbyterian Hospital, a district hospital in
the Ashanti region of Ghana [14]. For the current study,
stool samples from children below 6 years of age visiting
the hospital’s OPD between June 2007 and October 2008
Table 2 Shown are results for the Luminex GPP assay according








positive, n = (%)
G1[P8] 25 20.3 (19.3–22.8) 25 (100)
G2[P4] 17 21 (19.3–22.6) 17 (100)
G2[P6] 12 20.4 (18.8–21.9) 12 (100)
G2[P-UDa] 7 25.1 (21.7–27.2) 7 (100)
G3[P6] 3 22.1 (20–23.1) 3 (100)
Total 64 21 (19.6–23.3) 64 (100)
Abbreviations: IQR interquartile range; Ct cycle threshold, GPP
gastrointestinal pathogens
a UD, undetermined
Fig. 2 MFI-values according to qRT-PCR cycle threshold values.
Shown are MFI-values using the GPP assay in four different groups
with qRT-PCR Ct-values <20, 20–24, 25–29, and >30. The horizontal
dotted line indicates the GPP threshold of 150 MFI for positivity
Fig. 1 Distribution of qRT-PCR cyle threshold values. Shown are qRT-PCR
cycle threshold values in GPP-positive and GPP-negative samples among
cases and controls
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were selected. Children with diarrhoea, defined as at
least three loose stools within the last 24 h, served as
cases. During the same period, children attending the
OPD without gastrointestinal symptoms were recruited
as controls. A total of 682 samples were selected for this
study. Of these, 341 samples were from cases and an-
other 341 were from controls.
Immediately after stool collection, the samples were fro-
zen at −20 °C and shipped on dry ice to Germany for fur-
ther analyses as described elsewhere [14]. Following nucleic
acid extraction from 200 mg stool samples were analyzed
using the GPP (Luminex Corporation, Austin, TX) accord-
ing to the manufacturer’s instructions. The results for rota-
virus are reported in median fluorescence intensity (MFI)
values from each sample. A published rotavirus qRT-PCR
was used as the reference assay [15]. Briefly, a qRT-PCR
targeting the NSP3 gene was used to detect rotavirus nu-
cleic acids. A 25-μl reaction contained 5 μl of prepared nu-
cleic acids (the same as used for the GPP), 2× AgPath-ID
One-Step RT-PCR buffer (Thermo Fisher, Darmstadt,
Germany), 0.4 μM primer JVKF (CAGTGGTTGATGCT-
CAAGATGGA; TIB-Molbiol, Berlin, Germany), 0.4 μM
primer JVKR (TCATTGTAATCATATTGAATACCCA,
TIB-Molbiol), 0.2 μM probe JVKP (ACAACTGCAGCTT-
CAAAAGAAGWGT). Probe JVKP was labeled with 5′
FAM and a 3′ nonfluorescent quencher (TIB-Molbiol).
The cycling conditions in an ABI Prism 7500 machine
(Thermo Fisher) were as follows: 50 °C for 15 min, 95 °C
for 10 min, and 45 cycles of 95 °C for 10 s and 60 °C for
35 s. The data were analyzed with the Sequence detector
software V 2.0.6 (Thermo Fisher). Positive and no-template
controls were included in each PCR run.
The analytical sensitivity of the qRT-PCR was 12.5 in
vitro-transcribed RNA copies per reaction [95 % confi-
dence interval (CI) 9.6 to 20.9 RNA copies per reaction]
as determined using probit analysis. The rotavirus
strains were G and P genotyped by sequencing according
to Iturizza-Gomara et al. [16]. The Fast Track Diagnostics
(FTD) viral gastroenteritis kit (Junglingster, Luxemburg)
was used to analyze discrepant results between GPP and
qRT-PCR. A sample was considered GPP false-positive if
both the qRT-PCR and the viral gastroenteritis kit yielded
a negative rotavirus result.
All statistical analyses were done using the Graph-
Pad Prism software package (GraphPad, San Diego,
CA, USA). Median cycle threshold (Ct)-values and
MFI-values between two groups was compared using
Wilcoxon rank sum test. Differences in the detection
frequency of rotavirus using GPP and qRT-PCR in
cases and controls were assessed with Fisher’s exact
test. A p-value of <0.05 was considered statistically
significant. Correlation between qRT-PCR Ct-values
and GPP MFI-values was assessed using the Pearson
correlation coefficient. The Committee on Human Re-
search, Publications and Ethics, School of Medical
Science, Kwame Nkrumah University of Science and
Technology, Kumasi, Ghana, approved the study de-
sign and the informed consent procedure.
Abbreviations
CI, confidence interval; Ct-value, cycle threshold value; EIA, enzyme-linked im-
munosorbent assay; GPP, gastrointestinal pathogens panel; IQR, interquartile
range; MFI, mean fluorescence intensity; OPD, Outpatients Department; qRT-
PCR, quantitative reverse-transcription polymerase chain reaction.
Table 3 Number and percentage of co-detections among rotavirus GPP-positive and rotavirus GPP-negative samples
Rotavirus GPP-positive, n = 67 Rotavirus GPP-negative, n = 615
Pathogen n=, (%) n=, (%) p-value*
Adenovirus 40/41 4 (6) 27 (4) 0,5338
Norovirus GI/GII 3 (4) 63 (10) 0,1884
Campylobacter spp. 19 (28) 212 (34) 0344
Clostridium difficile toxin A/B 1 (1) 3 (0,5) 0,3394
Cryptosporidium spp. 1 (1) 44 (7) 0,1137
Entamoaba histolytica 0 (0) 3 (0,5) 1
Escherichia coli LT/ST (ETEC) 29 (43) 362 (59) 0,0187
Escherichia coli O157 2 (3) 94 (15) 0,0029
Escherichia coli STEC (stx1/2) 1 (1) 20 (3) 0,7115
Giardia lamblia 28 (42) 325 (53) 0,0947
Salmonella spp. 6 (9) 84 (14) 0,3445
Shigella spp. 15 (22) 246 (40) 0,0052
Yersinia enterocolitica 0 (0) 0 (0) 1
Vibrio cholerae 0 (0) 0 (0) 1
*Fisher’s exact test
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